With DRA Consulting Oy, you can look forward to getting your pharmaceuticals and health technology products to market quickly. And you can rely on our experts to handle the whole life cycle of your products, including regulatory procedures, strategies, market access and maintenance. Get in touch, we will give your business the boost it needs in the Nordic countries and Europe-wide.
Services for pharmaceuticals
DRA Consulting Oy provides expert services for pharmaceutical and healthcare companies. Our services cover everything from planning to implementation, including comprehensive management of business-critical activities.Learn more
Services for Health Technology
DRA Consulting Oy offers expert services to companies who manufacture and sell health technology products, including medical devices and in vitro diagnostics (IVD).Learn more
Continuous life cycle managementIt takes more than the correct documentation to ensure successful market access – it takes continuous attention to detail before, during and after the application process. DRA has the expertise and the resources to deal with regulatory requirements throughout the whole life cycle of pharmaceuticals and health technology products, including strategies, market access and maintenance. Our team also follows the changing regulatory environment to ensure continued compliance.
A strong strategy ensures a smooth process from product development to market access and regulatory issues related to sales and marketing of pharmaceuticals and medical devices.
Gaining market access for pharmaceuticals and medical devices in the Nordics requires special expertise. Ensure the most reliable and fastest way to market.
Stay up-to-date with the latest from regulatory affairs on our News & Blogs site. You can also contact us to find out more about our services for pharmaceutical and health technology companies.
New drug substances manufacturing site GMP certified thanks to DRA’s expertise
When building up a new drug substances manufacturing site, our client needed consultation on the GMP requirements, and to complement their own resources, a team of GMP and pharmaceutical chemical experts from DRA was set up.
A sneak peek to the future: ÄLY seminar puts the spotlight on finnish innovations and solutions for sustainable drug development
In this year’s ÄLY seminar organised by DRA, the discussion turned around different future visions about green pharmacy, corporate social responsibility, the latest innovations in health technology and the possibilities that quantum technology can offer for drug development.